ALDOL REACTION;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL CULTURE;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
IC 50;
IN VITRO STUDY;
Evidence for a key role of steroids in the modulation of pain
Evidence for a key role of steroids in the modulation of pain. Mensah-Nyagan AG, Meyer L, Schaeffer V, Kibaly C, Patte-Mensah C, Psychoneuroendocrino 2009 34 169 177
Use of steroid profiles in determining the cause of adrenal insufficiency
DOI 10.1016/j.steroids.2006.11.001, PII S0039128X06002182
Use of steroid profiles in determining the cause of adrenal insufficiency. Holst JP, Soldin SJ, Tractenberg RE, Guo T, Kundra P, Verbalis JG, Steroids 2007 72 71 84 10.1016/j.steroids.2006.11.001 17157339 (Pubitemid 46037764)
7-Hydroxy androstene steroids and a novel synthetic analogue with reduced side effects as a potential agent to treat autoimmune diseases
10.1016/j.autrev.2008.11.011 19071234
7-Hydroxy androstene steroids and a novel synthetic analogue with reduced side effects as a potential agent to treat autoimmune diseases. Auci DL, Reading CL, Frincke JM, Autoimmun Rev 2009 8 369 372 10.1016/j.autrev.2008.11. 011 19071234
Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: Inhibition by novel non-steroidal steroid sulfatase inhibitors
10.1016/S0960-0760(00)00077-7
Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors. Billich A, Nussbaumer P, Lehr P, J Steroid Biochem 2000 73 225 235 10.1016/S0960-0760(00)00077-7
Design, synthesis, cytocidal activity and estrogen receptor alpha affinity of doxorubicin conjugates at 16alpha-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer
10.1016/j.steroids.2012.06.004 22801351
Design, synthesis, cytocidal activity and estrogen receptor alpha affinity of doxorubicin conjugates at 16alpha-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer. Saha P, Fortin S, Leblanc V, Parent S, Asselin E, Berube G, Steroids 2012 77 1113 1122 10.1016/j.steroids.2012.06.004 22801351
Stereoselective synthesis of some methyl-substituted steroid hormones and their in vitro cytotoxic activity against human gastric cancer cell line MGC-803
10.1016/j.steroids.2010.05.008 20493894
Stereoselective synthesis of some methyl-substituted steroid hormones and their in vitro cytotoxic activity against human gastric cancer cell line MGC-803. Li C, Qiu W, Yang Z, Luo J, Yang F, Liu M, Steroids 2010 75 859 869 10.1016/j.steroids.2010.05.008 20493894
Synthesis and cytotoxicity of 17E-(2-aryl-2-oxo-1-ethylidene)-5alpha- androstane derivatives
10.1016/j.steroids.2011.10.003 22027219
Synthesis and cytotoxicity of 17E-(2-aryl-2-oxo-1-ethylidene)-5alpha- androstane derivatives. Li Y, Huang J, Liu J, Yan P, Liu H, Sun Q, Steroids 2011 76 1615 1620 10.1016/j.steroids.2011.10.003 22027219
New cytotoxic steroids from the soft coral Clavularia viridis
DOI 10.1016/j.steroids.2007.03.010, PII S0039128X07000542
New cytotoxic steroids from the soft coral Clavularia viridis. Duh CY, Lo IW, Wang SK, Dai CF, Steroids 2007 72 573 579 10.1016/j.steroids.2007.03.010 17485104 (Pubitemid 46764795)
New androst-4-en-17-spiro-1,3,2-oxathiaphospholanes. Synthesis, assignment of absolute configuration and in vitro cytotoxic and antimicrobial activities
10.1016/j.steroids.2012.01.021 22342468
New androst-4-en-17-spiro-1,3,2-oxathiaphospholanes. Synthesis, assignment of absolute configuration and in vitro cytotoxic and antimicrobial activities. Krstic NM, Bjelakovic MS, Pavlovic VD, Robeyns K, Juranic ZD, Matic I, Steroids 2012 77 558 565 10.1016/j.steroids.2012.01.021 22342468
Synthesis and aromatase inhibitory activity of some new 16E-arylidenosteroids
23064126
Synthesis and aromatase inhibitory activity of some new 16E-arylidenosteroids. Bansal R, Thota S, Karkra N, Minu M, Zimmer C, Hartmann RW, Bioorg Chem 2012 45 36 40 23064126
Synthesis and cytotoxic studies of hydroximino derivatives of some 16E-arylidenosteroids
Synthesis and cytotoxic studies of hydroximino derivatives of some 16E-arylidenosteroids. Chattopadhaya R, Jindal DP, Minu M, Gupta R, Arzneimittel-Forsch 2004 54 551 556 (Pubitemid 39274017)
Elucidation of thioredoxin as a molecular target for antitumor quinols
DOI 10.1158/0008-5472.CAN-04-4141
Elucidation of thioredoxin as a molecular target for antitumor quinols. Bradshaw TD, Matthews CS, Cookson J, Chew EH, Shah M, Bailey K, Cancer Res 2005 65 3911 3919 10.1158/0008-5472.CAN-04-4141 15867391 (Pubitemid 40616373)
Dehydroepiandrosterone and its metabolites: Differential effects on androgen receptor trafficking and transcriptional activity
10.1016/j.jsbmb.2005.11.011
Dehydroepiandrosterone and its metabolites: differential effects on androgen receptor trafficking and transcriptional activity. Mo Q, Lu SF, Simon NG, J Steroid Biochem 2006 99 50 58 10.1016/j.jsbmb.2005.11.011
ATP depletion is an important factor in DHEA-induced growth inhibition and apoptosis in BV-2 cells
DOI 10.1016/S0024-3205(01)01542-9, PII S0024320501015429
ATP depletion is an important factor in DHEA-induced growth inhibition and apoptosis in BV-2 cells. Yang NC, Jeng KC, Ho WM, Hu ML, Life Sci 2002 70 1979 1988 10.1016/S0024-3205(01)01542-9 12148690 (Pubitemid 34215123)
(2002)Life Sciences, vol.70, Issue.17, pp. 1979-1988
Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women
10.1158/0008-5472.CAN-05-3369 16489055
Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Tworoger SS, Sluss P, Hankinson SE, Cancer Res 2006 66 2476 2482 10.1158/0008-5472.CAN-05-3369 16489055
Asymmetrical 2, 6-bis (benzylidene) cyclohexanones: Synthesis, cytotoxic activity and QSAR study
22341788
Asymmetrical 2, 6-bis (benzylidene) cyclohexanones: Synthesis, cytotoxic activity and QSAR study. Nakhjiri M, Safavi M, Alipour E, Emami S, Atash AF, Jafari-Zavareh M, Eur J Med Chem 2012 50 113 123 22341788
Anti-proliferative and apoptotic effects of the derivatives from 4-aryl-4H-chromene family on human leukemia K562 cells
10.1007/s12272-012-0908-y 23054714
Anti-proliferative and apoptotic effects of the derivatives from 4-aryl-4H-chromene family on human leukemia K562 cells. Aryapour H, Mahdavi M, Mohebbi SR, Zali MR, Foroumadi A, Arch Pharm Res 2012 35 1573 1582 10.1007/s12272-012-0908-y 23054714
Cytotoxic activity evaluation and QSAR study of chromene-based chalcones
10.1007/s12272-012-1208-2 23263805
Cytotoxic activity evaluation and QSAR study of chromene-based chalcones. Firoozpour L, Edraki N, Nakhjiri M, Emami S, Safavi M, Ardestani SK, Arch Pharm Res 2012 35 2117 2125 10.1007/s12272-012-1208-2 23263805
A new strategy based on pharmacophore-based virtual screening in adenosine deaminase inhibitors detection and in-vitro study
10.1186/2008-2231-20-64
A new strategy based on pharmacophore-based virtual screening in adenosine deaminase inhibitors detection and in-vitro study. Bazl R, Ganjali MR, Saboury AA, Foroumadi A, Nourozi P, Amanlou M, DARU J Pharmaceut Sci 2012 20 64 69 10.1186/2008-2231-20-64
Induction of apoptosis through tubulin inhibition in human cancer cells by new chromene-based chalcones
10.3109/13880209.2012.695799 22984888
Induction of apoptosis through tubulin inhibition in human cancer cells by new chromene-based chalcones. Aryapour H, Riazi GH, Ahmadian S, Foroumadi A, Mahdavi M, Emami S, Pharm Biol 2012 50 1551 1560 10.3109/13880209.2012.695799 22984888
5,6-Dimethoxybenzofuran-3-one derivatives: A novel series of dual Acetylcholinesterase/Butyrylcholinesterase inhibitors bearing benzyl pyridinium moiety
10.1186/2008-2231-21-15
5,6-Dimethoxybenzofuran-3-one derivatives: a novel series of dual Acetylcholinesterase/Butyrylcholinesterase inhibitors bearing benzyl pyridinium moiety. Nadri H, Pirali-Hamedani M, Moradi A, Sakhteman A, Vahidi A, Sheibani V, Asadipour A, Hosseinzadeh N, Abdollahi M, Shafiee A, Foroumadi A, DARU J Pharmaceut Sci 2013 21 15 23 10.1186/2008-2231-21-15